Based on his personal experiences in the hospital setting, Patrick White reviews the factors that organizations should consider when measuring the success of their transitional care programs.
Mr White explains that, rather than focusing only on quality and short-term costs, organizations need to also assess the long-term costs of their programs to better determine overall cost-effectiveness.
Mr White discusses how some programs are beginning to consider improved technology options and higher-cost tools that, in the long-run, will reduce costs. However, he explains that developing a standardized model to measure what is truly effective will take several years, as there are so many disease cases to explore.
Lp(a) and Getting a Head Start Against Heart Disease: Jeremy Wigginton, MD
April 8th 2025Lipoprotein a (Lp[a]) is a valuable tool for assessing a patient's risk of cardiovascular disease, which can facilitate earlier intervention efforts and reduce health care costs, argued Jeremy Wigginton, MD.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More